verteporfin 15 MG Injection

RxCUI: 313595
RxNorm name: verteporfin 15 MG Injection
Display name: verteporfin 15 MG Injection
Full name: verteporfin 15 MG Injection
Term type: SCD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:09

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Visudyne	VERTEPORFIN FOR INJECTION	Bausch Health US LLC	952f4c80-50b1-4308-9ee6-311ffefb13df	2025-08-27	Warnings, Adverse reactions	Exact identifier rxcui: 313595
Visudyne	VERTEPORFIN FOR INJECTION	Bausch & Lomb Incorporated	2f0a34ce-3c57-4ac8-b28e-512be807272f	2023-02-24	Warnings, Adverse reactions	Exact identifier rxcui: 313595

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
952f4c80-50b1-4308-9ee6-311ffefb13df	verteporfin 15 MG Injection [PSN] · verteporfin 15 MG Injection [SCD]	2	15	These highlights do not include all the information needed to use VISUDYNE safely and effectively. See full prescribing information for VISUDYNE. VISUDYNE ® (verteporfin for injection), for intravenous use Initial U.S. Approval: 2000	20250827
2f0a34ce-3c57-4ac8-b28e-512be807272f	verteporfin 15 MG Injection [PSN] · verteporfin 15 MG Injection [SCD]	2	5	These highlights do not include all the information needed to use VISUDYNE safely and effectively. See full prescribing information for VISUDYNE. VISUDYNE ® (verteporfin for injection), for intravenous use Initial U.S. Approval: 2000	20230224